T
The Cooper Companies
Global medical device company publicly traded on the nyse euronext (nyse:coo)
About The Cooper Companies
The Cooper Companies is a global medical device company that operates through two main business units: CooperVision and CooperSurgical.
CooperVision is a leading manufacturer of contact lenses, offering a wide range of products for various vision correction needs. This segment of the business focuses on product innovation, manufacturing, and distribution to deliver high-quality contact lenses to a global market.
CooperSurgical specializes in medical devices, fertility, and genomic products for the women's healthcare market. This unit provides a diverse portfolio of products and services that support women through every stage of their reproductive journey, from contraception to advanced reproductive treatments. The business model is vertically integrated, which allows for control over the entire product lifecycle, from research and development to manufacturing and distribution. The company generates revenue through the sale of its medical devices and services to healthcare providers and consumers worldwide.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Feb 2026 | $0 | — | Undisclosed | ↗ |
| POST IPO EQUITY✓Other financing | Oct 2025 | $0 | — | JANA Partners | ↗ |
Growth signals
Latest recorded traffic for The Cooper Companies is 19K monthly website visits, up 387.2% over the last three months. The Cooper Companies's team grew 0% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
OBP SurgicalLawrence, United StatesDevelops single-use, cordless illuminating surgical devices for improved clinical efficiency and patient safety
$100Mvaluation
Generate Life SciencesLos Angeles, United States
$1.6Bvaluation
The LifeGlobal GroupGuilford, United StatesPrivately held company that specializes primarily in ivf media
$125Mvaluation
Teva Pharmaceutical - PARAGARDOverland Park, United States
$1.1Bvaluation
RecombineNew York City, United StatesGenetic Testing. Simplified.
$34Mvaluation
SP
Sauflon PharmaceuticalsUnited KingdomSauflon is a global manufacturer of contact lenses and aftercare solutions
→
OS
Ocular SciencesConcord, United StatesOcular Sciences Inc engages in the design, manufacture, and distribution of contact lenses
$600Mvaluation
The Cooper Companies in the San Ramon ecosystem
The The Cooper Companies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
- JPJANA Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about The Cooper Companies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See The Cooper Companies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









